News | May 23, 2023
Freenome acquires global immunodiagnostics developer Oncimmune
Acquisition enhances Freenome's product portfolio, including autoantibody platform with additional biomarkers important in cancer detection
Acquisition enhances Freenome's product portfolio, including autoantibody platform with additional biomarkers important in cancer detection
Venlafaxine HCl extended-release capsules are indicated for the treatment of: Major Depressive Disorder
Farxiga is expected to have such a strong influence on the market due to the impressive results
The facility will have a capacity to manufacture upto 3 million tubes monthly
Dr. Reddy's Laboratories has been issued a Form 483 with four observations
The Awards recognizes standout digital health & medical technology products and companies
The partnership will commercialize four nasal sprays with a combined Global IQVIA market size in excess of $400m
Indoco expects this change in compliance status to pave the way for approvals of ANDAs submitted from this site.
Once approved, Columvi will be the first CD20xCD3 T-cell-engaging bispecific antibody available to treat people in Europe with this aggressive lymphoma
Subscribe To Our Newsletter & Stay Updated
